https://www.theedgemarkets.com/article/astrazeneca-says-its-antibody-treatment-failed-preventing-covid19-exposed-patients
BENGALURU (June 15): Anglo-Swedish drug maker AstraZeneca said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Covid-19 in people recently exposed to the novel coronavirus.The company said…
Create an account or login to join the discussion